MÜV

MÜV (often stylized as MueV) is a brand of medical cannabis products developed by AltMed (Alternative Medical Enterprises), which is now a subsidiary of Verano Holdings. The brand is distinguished by its pharmaceutical-grade approach to medical marijuana, utilizing advanced drug delivery technologies to enhance the efficacy, bioavailability, and reliability of cannabinoid treatments. A key feature of MÜV products is the incorporation of DehydraTECH, a patented delivery technology licensed from Lexaria Bioscience that improves the absorption and speed of onset for orally and transdermally administered cannabinoids. MÜV's product line includes specialized formats such as 72-hour transdermal patches, metered-dose inhalers (MDI), oral sprays, and "EnCaps" encapsulated capsules. These products are primarily indicated for the management of conditions such as chronic pain, anxiety, epilepsy, and symptoms associated with cancer and multiple sclerosis, particularly in the Florida medical marijuana market.

Brand names

MÜV

Other names

MueVMUV